Telomere length and expression of human telomerase reverse transcriptase splice variants in chronic lymphocytic leukemia

Marzia Palma(Karolinska University Hospital), Håkan Mellstedt(Karolinska University Hospital), Anders Österborg(Karolinska University Hospital), Lotta Hansson(Karolinska Institutet), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Jade Forster(Royal Bournemouth Hospital), Anton Parker(Royal Bournemouth Hospital), Parviz Kokhaei(Arak University of Medical Sciences)
Experimental Hematology
March 30, 2013
10.1016/j.exphem.2013.03.008
Cited by 17

Related Papers

Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
Treatment of Anemia in Myelodysplastic Syndromes With Granulocyte Colony-Stimulating Factor Plus Erythropoietin: Results From a Randomized Phase II Study and Long-Term Follow-Up of 71 Patients
|Blood|1998|306
CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.
|Journal of Clinical Oncology|1998|258
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
|International Journal of Molecular Sciences|2014|202